Interpharm Holdings Stock Net Income
| IPAH Stock | USD 0 0.00 0.00% |
Interpharm Holdings technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Interpharm Holdings Total Revenue |
|
| Last Reported | Projected for Next Year | ||
| Net Loss | -15.1 M | -14.4 M | |
| Net Loss | -12.7 M | -12 M | |
| Net Loss | -12.7 M | -12 M | |
| Net Loss | (0.19) | (0.20) | |
| Net Income Per E B T | 0.91 | 0.63 |
Interpharm | Net Income | Build AI portfolio with Interpharm Stock |
Latest Interpharm Holdings' Net Income Growth Pattern
Below is the plot of the Net Income of Interpharm Holdings over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Interpharm Holdings financial statement analysis. It represents the amount of money remaining after all of Interpharm Holdings operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Interpharm Holdings' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Interpharm Holdings' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (14.06 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Interpharm Net Income Regression Statistics
| Arithmetic Mean | (13,010,988) | |
| Geometric Mean | 11,032,926 | |
| Coefficient Of Variation | (26.73) | |
| Mean Deviation | 1,724,491 | |
| Median | (14,058,000) | |
| Standard Deviation | 3,478,159 | |
| Sample Variance | 12.1T | |
| Range | 14.4M | |
| R-Value | (0.32) | |
| Mean Square Error | 11.6T | |
| R-Squared | 0.1 | |
| Significance | 0.22 | |
| Slope | (217,383) | |
| Total Sum of Squares | 193.6T |
Interpharm Net Income History
Other Fundumenentals of Interpharm Holdings
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Interpharm Holdings Net Income component correlations
Interpharm Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Interpharm Holdings is extremely important. It helps to project a fair market value of Interpharm Stock properly, considering its historical fundamentals such as Net Income. Since Interpharm Holdings' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Interpharm Holdings' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Interpharm Holdings' interrelated accounts and indicators.
Click cells to compare fundamentals
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Interpharm Holdings. If investors know Interpharm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Interpharm Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets | Return On Equity |
The market value of Interpharm Holdings is measured differently than its book value, which is the value of Interpharm that is recorded on the company's balance sheet. Investors also form their own opinion of Interpharm Holdings' value that differs from its market value or its book value, called intrinsic value, which is Interpharm Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Interpharm Holdings' market value can be influenced by many factors that don't directly affect Interpharm Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Interpharm Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Interpharm Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Interpharm Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Interpharm Holdings 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Interpharm Holdings' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Interpharm Holdings.
| 10/29/2025 |
| 01/27/2026 |
If you would invest 0.00 in Interpharm Holdings on October 29, 2025 and sell it all today you would earn a total of 0.00 from holding Interpharm Holdings or generate 0.0% return on investment in Interpharm Holdings over 90 days. Interpharm Holdings, Inc. develops, manufactures, and markets generic prescription strength and over-the-counter pharmac... More
Interpharm Holdings Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Interpharm Holdings' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Interpharm Holdings upside and downside potential and time the market with a certain degree of confidence.
Interpharm Holdings Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Interpharm Holdings' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Interpharm Holdings' standard deviation. In reality, there are many statistical measures that can use Interpharm Holdings historical prices to predict the future Interpharm Holdings' volatility.Interpharm Holdings Backtested Returns
We have found three technical indicators for Interpharm Holdings, which you can use to evaluate the volatility of the firm. The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Interpharm Holdings are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
Interpharm Holdings has no correlation between past and present. Overlapping area represents the amount of predictability between Interpharm Holdings time series from 29th of October 2025 to 13th of December 2025 and 13th of December 2025 to 27th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Interpharm Holdings price movement. The serial correlation of 0.0 indicates that just 0.0% of current Interpharm Holdings price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Interpharm Holdings reported net income of (14.06 Million). This is 104.12% lower than that of the Pharmaceuticals sector and 120.07% lower than that of the Health Care industry. The net income for all United States stocks is 102.46% higher than that of the company.
Interpharm Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Interpharm Holdings' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Interpharm Holdings could also be used in its relative valuation, which is a method of valuing Interpharm Holdings by comparing valuation metrics of similar companies.Interpharm Holdings is currently under evaluation in net income category among its peers.
Interpharm Fundamentals
| Return On Equity | -1.17 | ||||
| Return On Asset | -0.19 | ||||
| Profit Margin | (0.42) % | ||||
| Operating Margin | (0.24) % | ||||
| Current Valuation | 2.07 M | ||||
| Number Of Shares Shorted | 1.13 M | ||||
| Price To Sales | 0.03 X | ||||
| Revenue | 75.59 M | ||||
| Gross Profit | 12 M | ||||
| EBITDA | (16.57 M) | ||||
| Net Income | (14.06 M) | ||||
| Cash And Equivalents | 41 K | ||||
| Total Debt | 12.06 M | ||||
| Debt To Equity | 3.43 % | ||||
| Current Ratio | 0.62 X | ||||
| Book Value Per Share | (0.08) X | ||||
| Cash Flow From Operations | (14.11 M) | ||||
| Short Ratio | 289.66 X | ||||
| Earnings Per Share | (0.09) X | ||||
| Number Of Employees | 670 | ||||
| Beta | -56.0 | ||||
| Market Capitalization | 2.07 M | ||||
| Total Asset | 74.37 M | ||||
| Working Capital | (16.64 M) | ||||
| Current Asset | 27.38 M | ||||
| Current Liabilities | 44.01 M | ||||
| Net Asset | 74.37 M |
About Interpharm Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Interpharm Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Interpharm Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Interpharm Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Interpharm Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Interpharm Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Interpharm Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Interpharm Holdings Stock:Check out Interpharm Holdings Piotroski F Score and Interpharm Holdings Altman Z Score analysis. For more detail on how to invest in Interpharm Stock please use our How to Invest in Interpharm Holdings guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Interpharm Holdings. If investors know Interpharm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Interpharm Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets | Return On Equity |
The market value of Interpharm Holdings is measured differently than its book value, which is the value of Interpharm that is recorded on the company's balance sheet. Investors also form their own opinion of Interpharm Holdings' value that differs from its market value or its book value, called intrinsic value, which is Interpharm Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Interpharm Holdings' market value can be influenced by many factors that don't directly affect Interpharm Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Interpharm Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Interpharm Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Interpharm Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.